Brief report · 29 Dec 2025
Mini reviewPublished 24 Jun 2024
Understanding the Molecular Epidemiology of Multi-Drug Resistant Tuberculosis in High-Burden Regions
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tuberculosis (TB) remains a significant global health challenge, particularly in high-burden regions. The emergence of Multi-Drug Resistant Tuberculosis (MDR-TB) complicates treatment strategies and exacerbates public health concerns. Molecular epidemiology provides critical insights into the transmission dynamics, genetic diversity and resistance mechanisms of MDR-TB, enabling more targeted and effective interventions. Tuberculosis is an infectious disease caused by the bacterium Mycobacterium tuberculosis. Despite significant advances in medicine and public health, TB remains a major global health concern, particularly in low- and middle-income countries. Understanding the epidemiology, diagnosis, treatment and prevention of TB is crucial for effective control and eventual eradication of this disease. TB is one of the top 10 causes of death worldwide and the leading cause of death from a single infectious agent, ranking above HIV/AIDS.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Infectious Diseases: Open Access.
Brief report · 29 Dec 2025
Preventing MDROs in ICUs: A Comprehensive Approach
Commentary · 29 Dec 2025
Combating Multidrug-Resistant Organisms: A Multilayered Approach
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Infectious Diseases: Open Access
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Torres Ruiz”
